A

Altus Research | Women's Health Studies

Research site
(Unclaimed)
Location
4761 South Congress Avenue, Suite 100-B, Lake Worth, Florida, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

10 of 55
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab (ADapt)

The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) pre...

Active, not recruiting
Atopic Dermatitis
Drug: Lebrikizumab

This study will be in two parts, Part A and Part B. The primary objective of Part A is to evaluate the contraceptive efficacy of LPRI-CF113. The seco...

Active, not recruiting
Contraception
Change in Bone Mineral Density
Drug: Drospirenone

This is a two-part study designed to evaluate the effect of Estetrol (E4) 15 or 20 mg, or placebo on the severity and frequency of vasomotor symptoms...

Active, not recruiting
Menopausal Symptoms
Vasomotor Symptoms
Drug: Progesterone oral tablet
Drug: Estetrol oral tablet

To assess the contraceptive efficacy (prevention of pregnancy) of VeraCept

Active, not recruiting
Women at Risk for Pregnancy
Drug: VeraCept

The role of nutrition is recognized as a vital component to healthy aging throughout menopause. The goal of this study is to evaluate a dietary suppl...

Enrolling
Postmenopausal Disorders
Vasomotor Symptoms
Dietary Supplement: JDS-HF 3.0
Dietary Supplement: Placebo

This is phase 3b study seeks to evaluate the safety of elagolix in combination with estradiol/norethindrone acetate for the management of heavy menst...

Active, not recruiting
Uterine Fibroids
Heavy Menstrual Bleeding
Other: E2/NETA Placebo
Drug: E2/NETA

A phase 2 study to assess the efficacy of bimagrumab alone or in addition to semaglutide to assess efficacy and safety in overweight or obese men and...

Active, not recruiting
Overweight or Obesity
Obese
Other: Bimagrumab Placebo
Biological: Bimagrumab

Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles

Active, not recruiting
Contraception
Drug: MR-100A-01

This study is designed to assess post-procedural outcomes for women who chose to undergo either hysteroscopic sterilization (Essure®) or laparoscopic...

Active, not recruiting
Contraception
Device: ESSURE (BAY1454032)
Procedure: Laparoscopic tubal sterilization

This is a Phase 2, multicenter, randomized, double-blinded, parallel dose group, placebo-controlled, dose-ranging study to evaluate the efficacy and...

Enrolling
Plaque Psoriasis
Drug: TLL018 tablets

Trial conditions

Candidiasis (7 trials)
Vulvovaginal Candidiasis (7 trials)
Hot Flashes (5 trials)
Leiomyoma (5 trials)
Myofibroma (5 trials)
Carcinoma in Situ (3 trials)
Cicatrix (3 trials)
Endometriosis (3 trials)
Hemorrhage (3 trials)
Menorrhagia (3 trials)

And 40 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems